Literature DB >> 20509844

Mitochondrial dysfunction during sepsis.

Luciano Cesar Pontes Azevedo1.   

Abstract

Sepsis and multiple organ failure remain leading causes of death in intensive care patients. Recent advances in our understanding of the pathophysiology of these syndromes include a likely prominent role for mitochondria. Patient studies have shown that the degree of mitochondrial dysfunction is related to the eventual outcome. Associated mechanisms include damage to mitochondria or inhibition of the electron transport chain enzymes by nitric oxide and other reactive oxygen species (the effects of which are amplified by co-existing tissue hypoxia), hormonal influences that decrease mitochondrial activity, and downregulation of mitochondrial protein expression. Notably, despite these findings, there is minimal cell death seen in most affected organs, and these organs generally regain reasonably normal function should the patient survive. It is thus plausible that multiple organ failure following sepsis may actually represent an adaptive state whereby the organs temporarily 'shut down' their normal metabolic functions in order to protect themselves from an overwhelming and prolonged insult. A decrease in energy supply due to mitochondrial inhibition or injury may trigger this hibernation/estivation-like state. Likewise, organ recovery may depend on restoration of normal mitochondrial respiration. Data from animal studies show histological recovery of mitochondria after a septic insult that precedes clinical improvement. Stimulation of mitochondrial biogenesis could offer a new therapeutic approach for patients in multi-organ failure. This review will cover basic aspects of mitochondrial function, mechanisms of mitochondrial dysfunction in sepsis, and approaches to prevent, mitigate or speed recovery from mitochondrial injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509844     DOI: 10.2174/187153010791936946

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  25 in total

1.  Hypoxia/oxidative stress alters the pharmacokinetics of CPU86017-RS through mitochondrial dysfunction and NADPH oxidase activation.

Authors:  Jie Gao; Xuan-sheng Ding; Yu-mao Zhang; De-zai Dai; Mei Liu; Can Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

2.  PGC-1α expression is increased in leukocytes in experimental acute pancreatitis.

Authors:  Flávia Llimona; Thais Martins de Lima; Ana Iochabel Moretti; Mariana Theobaldo; Jose Jukemura; Irineu Tadeu Velasco; Marcel C C Machado; Heraldo Possolo Souza
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  Importance of Toll-like receptor 2 in mitochondrial dysfunction during polymicrobial sepsis.

Authors:  Yu Gong; Lin Zou; Yan Feng; Dan Li; Jiayan Cai; Dunjin Chen; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

4.  Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.

Authors:  Geeta Datta; Philip A Kramer; Michelle S Johnson; Hirotaka Sawada; Lesley E Smythies; David K Crossman; Balu Chacko; Scott W Ballinger; David G Westbrook; Palgunachari Mayakonda; G M Anantharamaiah; Victor M Darley-Usmar; C Roger White
Journal:  Biochem J       Date:  2015-05-01       Impact factor: 3.857

5.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

6.  Poly (ADP-ribose) synthetase inhibitor has a heart protective effect in a rat model of experimental sepsis.

Authors:  Lianshuang Zhang; Jinpeng Yao; Xifeng Wang; Hongxing Li; Tongshen Liu; Wei Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Ethyl pyruvate reduces hepatic mitochondrial swelling and dysfunction in a rat model of sepsis.

Authors:  Zhiyi Jiang; Xiaoyue Li; Zongqin Lin; Juan Chen; Xiangdong Guan; Minying Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 8.  Sepsis-associated encephalopathy.

Authors:  Teneille E Gofton; G Bryan Young
Journal:  Nat Rev Neurol       Date:  2012-09-18       Impact factor: 42.937

9.  Clinical course and outcome for critically ill children with Down syndrome: a retrospective cohort study.

Authors:  Shane M Tibby; Andrew Durward; Chong Tien Goh; Kentigern Thorburn; Kevin Morris; Mike Broadhead; Mark J Peters
Journal:  Intensive Care Med       Date:  2012-05-15       Impact factor: 17.440

Review 10.  Septic-Associated Encephalopathy: a Comprehensive Review.

Authors:  Aurélien Mazeraud; Cássia Righy; Eleonore Bouchereau; Sarah Benghanem; Fernando Augusto Bozza; Tarek Sharshar
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.